doi: 10.1371/journal.pmed.0050113.
A user's guide to the NINDS rt-PA stroke trial database
Affiliations
- PMID: 18494557
- PMCID: PMC2386834
- DOI: 10.1371/journal.pmed.0050113
Item in Clipboard
A user's guide to the NINDS rt-PA stroke trial database
PLoS Med.
.
Abstract
Robert Dachs and colleagues describe the process for researchers to acquire and decipher the dataset from the original NINDS rt-PA trial.
Conflict of interest statement
Similar articles
-
National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.Stroke. 2008 Mar;39(3):924-8. doi: 10.1161/STROKEAHA.107.490375. Epub 2008 Jan 31. Stroke. 2008. PMID: 18239184
-
Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke.Stroke. 2004 Jan;35(1):147-50. doi: 10.1161/01.STR.0000105396.93273.72. Epub 2003 Dec 4. Stroke. 2004. PMID: 14657446
-
[Treatment with intravenous rt-PA in a general hospital context: A review of the Saint-Jean Hospital experience from Perpignan, France].Rev Neurol (Paris). 2006 Nov;162(11):1109-17. doi: 10.1016/s0035-3787(06)75123-2. Rev Neurol (Paris). 2006. PMID: 17086147 Clinical Trial. French.
-
Pathophysiology and mechanisms of acute ischemic stroke. The NINDS rt-PA Stroke Study Group.J Neurosci Nurs. 1997 Dec;29(6):356-60. doi: 10.1097/01376517-199712000-00004. J Neurosci Nurs. 1997. PMID: 9479656 Review.
-
Thrombolytic therapy for acute ischemic stroke.J Neurol Sci. 2007 Oct 15;261(1-2):55-62. doi: 10.1016/j.jns.2007.04.031. Epub 2007 Jul 5. J Neurol Sci. 2007. PMID: 17618652 Review.
Cited by
-
Use of recombinant tissue plasminogen activator in cancer patients with acute stroke.J Neurooncol. 2012 May;107(3):571-3. doi: 10.1007/s11060-011-0780-5. Epub 2011 Dec 18. J Neurooncol. 2012. PMID: 22179814
-
Stroke: Measuring disease-free life after thrombolysis.Nat Rev Neurol. 2010 Jul;6(7):361-2. doi: 10.1038/nrneurol.2010.79. Nat Rev Neurol. 2010. PMID: 20639913 No abstract available.
-
Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation - A microsimulation study.PLoS One. 2018 Jul 11;13(7):e0199593. doi: 10.1371/journal.pone.0199593. eCollection 2018. PLoS One. 2018. PMID: 29995900 Free PMC article.
-
TURN Score Predicts 24-Hour Cerebral Edema After IV Thrombolysis.Neurocrit Care. 2016 Jun;24(3):381-8. doi: 10.1007/s12028-015-0198-6. Neurocrit Care. 2016. PMID: 26341364 Clinical Trial.
-
TURN Score Predicts 90-day Outcome in Acute Ischemic Stroke Patients After IV Thrombolysis.Neurocrit Care. 2015 Oct;23(2):172-8. doi: 10.1007/s12028-015-0154-5. Neurocrit Care. 2015. PMID: 26032809
References
-
- The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med. 1995;333:1581–1587. - PubMed
-
- American Heart Association in Collaboraton with the International Liason Committee on Rususcitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 7: The era of reperfusion: Section 2: Acute stroke. Circulation. 2000;102(suppl I):1204–1216. - PubMed
-
- Quality Standards Subcommittee of the American Academy of Neurology, Practice Advisory. Thrombolytic therapy for acute ischemic stroke: Summary statement. Neurology. 1996;47:835–839. - PubMed
-
- Hoffman JR. Tissue plasminogen activator for acute ischemic stroke: Is the CAEP Position Statement too negative. Can J Emerg Med. 2001;3:183–185. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
